APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 73 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $53,178,000 | +29.9% | 2,098,581 | 0.0% | 1.70% | -0.6% |
| Q1 2019 | $40,922,000 | +47.8% | 2,098,581 | 0.0% | 1.71% | -17.7% |
| Q4 2018 | $27,680,000 | -64.0% | 2,098,581 | -51.5% | 2.07% | +0.8% |
| Q3 2018 | $76,957,000 | -19.2% | 4,328,289 | 0.0% | 2.06% | +26.7% |
| Q2 2018 | $95,222,000 | +201.5% | 4,328,289 | +203.0% | 1.62% | +191.4% |
| Q1 2018 | $31,586,000 | +1.9% | 1,428,571 | 0.0% | 0.56% | +5.9% |
| Q4 2017 | $31,000,000 | – | 1,428,571 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |